-
 Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) CEO Shares Personal Insight in Exclusive Interview
Kim Thompson, CEO of Kraig Biocraft, was recently featured by Small Cap Voice in an exclusive audio interview. During the interview, Mr. Thompson described the company’s business and targeted market, advantages of spider silk, gave background on his previous accomplishments, commented on the bright minds working within the company, provided his vision for the next 5-10 years, and much more.
To listen to this enlightening interview, visit: Kraig Biocraft
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Seeing the Bigger Picture – Putting the Potential Value of “Spider Silk” Technology into Perspective
While naturally produced spider silk has long been understood to have a superior level of tensile strength, research institutions and companies alike are seemingly on the verge of attaining the ability to harness this technology and apply it to various fields of endeavor. Sure, the idea of using such spider silk to swing from one building to another might be attractive to a certain comic book superhero fan club. In reality, however, the utility of this “packaged spider silk” could virtually spread across multiple, disparate applications in both governmental and commercial sectors. This concept of application versatility truly showcases this technology’s remarkable value for growth in the not-so-distant future.
Take Velcro back in the 1940’s, for example. This “zipperless zipper” idea came to a Swiss engineer named George de Mestra after witnessing seeds continually latching onto his clothes and his dog’s fur. In time, NASA was using it onboard their shuttles in both astronaut spacesuits and on-the-wall supply fasteners. After soon being incorporated in an array of leisure applications including skiing, surfing, and SCUBA, it further became utilized in nuclear power plants, automobiles, army tanks, combat uniforms, and footwear.
A packaged spider silk product would represent the same universal applicability as Velcro, thereby covering a vast array of commercialization areas. In terms of government utility, this spider silk can be used in ballistic armor and cables on board aircraft carriers. In terms of health-based utility, this material can be used in the creation of artificial ligaments or tendons as well as in the improvement of bandages and surgical thread. Further utility is foreseeable in the production of a number of commercial applications including lightweight clothing, fishing lines, seat belts, high strength cables, parachutes, biodegradable bottles, just to name a few.
Qualitystocks has identified the major players in this emerging industry which includes smaller companies represented by Kraig Biocraft Laboratories Inc (KBLB.OB), Angiotech International, Nexia Biotechnologies, and Oxford Biomaterials as well as the chemical giant, Dupont. Government organizations, consisting of the US Army, US Air Force, and the National Science Foundation, have also been actively funding spider silk research programs including Tufts University, Massachusetts Institute of Technology, and the University of California at Santa Barbara.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) CEO Joins QualityStocks for Exclusive Interview
Today, QualityStocks published a 6 minute interview featuring Kraig Biocraft CEO Kim Thompson. In the interview, Mr. Thompson commented on the business, the spider silk technology it is developing, the enormous market for spider silk, how the company has progressed, the milestones the management has set for this year as well as provided a synopsis of the company’s scientific team members.
To hear the entire interview, visit: QualityStocks Audio Interviews & Video Charts
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
The Status of Kraig Biocraft Laboratories, Inc. (KBLB.OB) Technology and Expected Time Frames
Kraig Biocraft Laboratories has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including spider silk, which may have numerous commercial and consumer applications.
The company possesses coded gene sequences that relate to spider silk production and is currently working on injecting this material into silkworm eggs. The team at the University of Notre Dame, led by Dr. Fraser, has recently been strengthened to further refine the microinjection process as well as increase the number of microinjections preformed.
In most recent news, the company excitedly announced that the scientific team has achieved the activation of fluorescent marker gene sequences that were incorporated into spider silk DNA packets by the researchers. The team has successfully inserted the DNA packets into silkworms, which are now visibly emitting florescence. This achievement is a huge step forward for Kraig Labs. The fact that these proteins are markers establishes that the DNA packets have been successfully transferred.
Kraig Biocraft has a particular focus within the biotech industry where FDA approval of its resulting technologies and products is not required. This means that once the company has produced the desired transgenic silkworm, it can immediately move into production, licensing agreements or a direct sale of the technology or of the entire company.
After achieving its goal of creating a line of silkworms capable of producing spider silk fibers in commercial quantities, the company will most likely decide one of two things. One choice would be selling the entire company or licensing the technology to one of the larger technical textile market participants. An alternative would be to pursue bulk sales of fibers produced by the transgenic silkworms. Because this would require significant additional financing and a greater amount of time to attain profits, an outright acquisition or a licensing agreement is more likely.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories Inc (KBLB.OB): Investing in People Who have Proven Themselves
Both existing and potential investors of Kraig Biocraft Laboratories Inc (KBLB.OB) should understand that they have one of the most pioneering and accomplished minds in the field of genetic engineering working in their corner. This member of Kraig’s Scientific Advisory Board, Dr. Malcolm Fraser, presides over the University of Notre Dame’s transgenic-based laboratory which has currently been focusing on developing “spider silk” polymers.
Since Kraig and Notre Dame have partnered in a collaboration agreement, essentially exchanging funding for both R&D data and intellectual property rights, Kraig is uniquely positioned to benefit from the work conducted under Dr. Fraser at Notre Dame. Consequently, the company’s stock performance will be heavily tied to Dr. Fraser’s breakthroughs in the laboratory.
Considering Kraig’s track record, investors should feel at ease with the notion that his work can single handedly affect Kraig’s stock price. Shortly after the turn of the century, Dr. Fraser patented what has become one of the most utilized methods directed to insert genes in insects. Since this US Patent 6,218,185 titled Piggybac transposon-based genetic transformation system for insects was issued, over 190 pending or patented applications have come through the United States Patent and Trademark Office.
A recent study also compared this Piggybac transposon to three other transposons commonly used for “jumping genes” into insects, and subsequently found the Piggybac transposon performed five to ten times better. As a result of this technical breakthrough pioneered by Dr. Fraser, universities across the globe have already paid over $300,000 to his group in licensing fees in order to use this Piggybac metholodology in their laboratories.
Now that Kraig has joined forces with Dr. Fraser, research and development has focused on incorporating this Piggybac technique in silkworms such that high performance spider silk polymers can be spun. The rapid progress in this area of spider silk has already been highlighted by the filing of at least two provisional patent applications under the assignee of the University of Notre Dame. While these applications have not been made public and have yet to be examined, this is a very welcoming sign of good things to come under the direction of Dr. Fraser and Kraig Biocraft Laboratories Inc.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) - Innovation in Genetic Engineering
Kraig Biocraft operates in a multi-billion dollar world market that has been growing by as much as 30 percent each year since the mid-Seventies. This market is Genetic Engineering. While some aspects of this relatively new science have become controversial due to many moral and legal implications, the work being done at Kraig Biocraft would be applauded by even the shrewdest skeptics. The end result of the research and development taking place at Kraig could very well improve our lives, without causing the same sort of harm associated with many areas of the field.
Human beings have been aware of the astonishing strength of certain types of spider silk for generations, yet have never been able to harness it for practical use. Scientists realized that while the silk itself could be reproduced artificially, its true strength was derived from the spinnerets (silk glands) of the spiders which produced it naturally. This realization led to a fundamental roadblock with respect to mass-production for commercial use which has stumped the scientific community for decades. Spiders are cannibalistic, rendering the formation of a collective large enough to produce adequate quantities of silk practically impossible.
The scientists at Kraig Biocraft believe that they have found the solution to this technical issue: The Silkworm. By inserting the genetic “code” for silk used by spiders into silkworms, which boast spider-like spinnerets, they believe it is possible to create a medium in which large amounts of this astronomically useful substance can be economically produced. The ramifications of their success will be far-reaching indeed. The possible areas of application for “packaged” spider silk include, but are not limited to: textiles, industrial netting, automotive (such as seatbelts and airbags), ropes and cables with unprecedented strength, as well as several architectural, military, aeronautic, and everyday uses.
The company holds proprietary genetic engineering technologies that will affect the successful commercialization of the finished product. It seems only a matter of time before spider silk replaces high-tensile steel as the preferred substance of engineers everywhere. If and when that happens, Kraig Biocraft Laboratories will likely be at the forefront of a revolution in the production of high-performance polymers that could change the world.
Please see disclaimer on QualityStocks website: QualityStocks
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Makes Substantial Progress in the Labs; Achieves New Company Record Ahead of Schedule
Today, Kraig Biocraft announced that Dr. Fraser’s research team has successfully made 5,000 genetic transfers in a single week using the newly designed DNA insertion packets. The Company anticipates having preliminary test results back on these five thousand genetic insertions within the next 45 days.
“Every DNA packet insertion has the potential to create a new recombinant fiber with commercial applications. The achievement of 5,000 such insertions in a single week is something that the Company would not have dreamed of in 2008,” CEO Kim K. Thompson enthusiastically stated. “At the same time, Dr. Fraser is reporting a large increase in the team’s observation of the occurrence of transient expression shortly after the gene transfers are preformed.” The research team believes this is a strong indication of the viability of the genetic transfers.
“More importantly,” added Mr. Thompson, “the research team is now performing these gene transfers in large numbers on a regular basis. That means that there will be a nearly continuous group of gene transfers benign tested. Every single gene insertion has the potential to create a new commercially viable spider silk polymer. With this number of gene insertions the odds of our developing a viable polymer are increasing exponentially.”
According to the press release, Kraig Biocraft believes these dramatic increases in productivity are the direct result of Mr. Thompson’s successful efforts to reorganize the research team in 2008.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Cleartronic Inc.’s (CLRI.OB) Innovative, Highly Functional Products
Cleartronic Inc., through its wholly owned subsidiary VoiceInterop, offers an array of hardware and software solutions that connect various incompatible communication devices. The company’s AudioMate360 Series link conventional two-way radios and other audio devices with an IP-communications network. Regardless if a business wishes to interoperate with its conventional or trunked/two-way system, a baseband audio source or even an iDEN network, the AudioMate360 line offers the most affordable and feature rich IP audio solution for unified communications today.
VoiceInterop’s AudioMate Unified Communications™ Software takes unified communications to another level by allowing authorized personnel to securely communicate using any radio, telephone or PC device; regardless of equipment manufacturer, system protocols or frequencies. Now, through their unique software, telephones, two-way radio systems and PCs can communicate with each other over one secure IP Network. By using the AudioMate Unified Communications™ Software, businesses can centralize access to all AudioMate360 products.
The VoiceInterop Command Phone is a solution that integrates modern, commercial off-the-shelf communication devices into a fiber-optic ring network. Command Phone brings traditional crash phone or crash-net solutions to the latest generation technology with a GUI-based management system, scalable design, and error free usability. Command Phone offers a level of flexibility that no traditional crash phone or crash-net system can compete against. Although Command Phone was first designed to address a need at commercial airports, it has also been customized for critical infrastructure, campus-wide emergency broadcasts, financial Hoot and Holler and cross-jurisdictional clients.
VoiceInterop also produces demo kits to showcase their unified communications and interoperability solutions in an easy to use road-kit. The Demo Kit allows clients and partners alike to experiment with its hardware appliances and software applications. With multiple versions to choose from, clients and partners can custom build their Demo Kit to meet any budgetary requirement. Once implemented, the Demo Kit can easily be scaled into a production system. Most importantly, each Demo Kit includes five hours of VoiceInterop certified engineer technical assistance.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) - Innovation in Genetic Engineering
Kraig Biocraft operates in a multi-billion dollar world market that has been growing by as much as 30 percent each year since the mid-Seventies. This market is Genetic Engineering. While some aspects of this relatively new science have become controversial due to many moral and legal implications, the work being done at Kraig Biocraft would be applauded by even the shrewdest skeptics. The end result of the research and development taking place at Kraig could very well improve our lives, without causing the same sort of harm associated with many areas of the field.
Human beings have been aware of the astonishing strength of certain types of spider silk for generations, yet have never been able to harness it for practical use. Scientists realized that while the silk itself could be reproduced artificially, its true strength was derived from the spinnerets (silk glands) of the spiders which produced it naturally. This realization led to a fundamental roadblock with respect to mass-production for commercial use which has stumped the scientific community for decades. Spiders are cannibalistic, rendering the formation of a collective large enough to produce adequate quantities of silk practically impossible.
The scientists at Kraig Biocraft believe that they have found the solution to this technical issue: The Silkworm. By inserting the genetic “code” for silk used by spiders into silkworms, which boast spider-like spinnerets, they believe it is possible to create a medium in which large amounts of this astronomically useful substance can be economically produced. The ramifications of their success will be far-reaching indeed. The possible areas of application for “packaged” spider silk include, but are not limited to: textiles, industrial netting, automotive (such as seatbelts and airbags), ropes and cables with unprecedented strength, as well as several architectural, military, aeronautic, and everyday uses.
The company holds proprietary genetic engineering technologies that will affect the successful commercialization of the finished product. It seems only a matter of time before spider silk replaces high-tensile steel as the preferred substance of engineers everywhere. If and when that happens, Kraig Biocraft Laboratories will likely be at the forefront of a revolution in the production of high-performance polymers that could change the world.
Last edited by QualityStocks; 02-11-2009 at 05:15 PM.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) - Increased Lab Productivity Draws Attention from Investors
As a result of yesterday’s announcement, which heralded a recent milestone achievement of Kraig Labs scientists, several promotional firms have initiated coverage of the company. In addition, a rising buzz in online investment communities’ message boards and chatrooms has been observed.
Kraig’s lab specialists have successfully accomplished a previously unheard-of number of genetic insertions using newly designed DNA “packets”. In a single week, they successfully transferred five thousand packets containing the genetic code for silk found in spiders to silkworm recipients. This increased productivity essentially means that the odds of Kraig Labs successfully developing a commercially feasible spider silk polymer have been greatly increased.
Following the release of the good news yesterday, respected firms like Stockguru.com swiftly took the opportunity to lend support. This, along with continual coverage by QualityStocks, helped propel Kraig Labs to its second highest daily trading volume of the new year.
It would arguably be unwise to allow Kraig Biocraft Laboratories to slip from one’s radar, especially during this exciting time of advancement in the company’s efforts to solve one of nature’s many riddles on a genetic level. Attacking the long-standing obstacles of spider silk production on a grand scale has the research team at Kraig Labs knocking on the door of a significant scientific breakthrough.
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Visit Homepage
Reply With Quote
Posting Permissions
Bookmarks